[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  ABBO News [@ABBONews](/creator/twitter/ABBONews) on x 14K followers Created: 2025-07-16 12:46:25 UTC 🚨Shares in Focus: Johnson & Johnson $JNJ shares are up XXXX% pre-market to $XXXXXX after beating Q2 earnings. 💰EPS came in at $2.77, compared to the $XXXX consensus estimate. 📈Revenue reached $XXXXX billion, surpassing forecasts, driven by strong demand for cancer drug Darzalex and medical device strength. Full-year sales forecast raised.  XXX engagements  **Related Topics** [jnj](/topic/jnj) [sales forecast](/topic/sales-forecast) [eps](/topic/eps) [$jnj](/topic/$jnj) [stocks](/topic/stocks) [johnson johnson](/topic/johnson-johnson) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/ABBONews/status/1945465041031246276)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
ABBO News @ABBONews on x 14K followers
Created: 2025-07-16 12:46:25 UTC
🚨Shares in Focus: Johnson & Johnson $JNJ shares are up XXXX% pre-market to $XXXXXX after beating Q2 earnings.
💰EPS came in at $2.77, compared to the $XXXX consensus estimate. 📈Revenue reached $XXXXX billion, surpassing forecasts, driven by strong demand for cancer drug Darzalex and medical device strength. Full-year sales forecast raised.
XXX engagements
Related Topics jnj sales forecast eps $jnj stocks johnson johnson stocks healthcare
/post/tweet::1945465041031246276